Kinexis' Unattributed VC Round

Kinexis raised a round of funding on April 21, 2003. Investors include Investbio.

Kinexis, Inc. is a life science R&D company targeting pathology-linked oligomeric conformations of amyloid proteins involved in neurodegenerative disorders such as Alzheimer's disease, Parkinson's dis…

Articles about Kinexis' Unattributed VC Round: